Inhibition of Toxoplasma gondii by indirubin and tryptanthrin analogs.
Bogdana Krivogorsky, Peter Grundt, Robert Yolken, Lorraine Jones-Brando
Index: Antimicrob. Agents Chemother. 52(12) , 4466-9, (2008)
Full Text: HTML
Abstract
New drugs are needed for treatment of Toxoplasma gondii infections. We tested derivatives of principles found in Isatis indigotica for in vitro efficacy against T. gondii infection. Indirubin-3'-oxime analogs showed modest micromolar activity, while tryptanthrin derivatives displayed 50% inhibitory doses in the low nanomolar range. Tryptanthrins have potential as anti-Toxoplasma infection therapeutics.
Related Compounds
Related Articles:
Tryptanthrin ameliorates atopic dermatitis through down-regulation of TSLP.
2014-01-15
[Arch. Biochem. Biophys. 542 , 14-20, (2014)]
2015-11-04
[J. Ethnopharmacol. 174 , 474-81, (2015)]
Kourokhitin, a potential drug containing two active substances.
2009-01-01
[Dokl. Biochem. Biophys. 426 , 131-3, (2009)]
2007-01-04
[J. Pharm. Biomed. Anal. 43(1) , 346-51, (2007)]
Specific stabilization of DNA triple helices by indolo[2,1-b]quinazolin-6,12-dione derivatives.
2007-03-15
[Bioorg. Med. Chem. Lett. 17(6) , 1769-72, (2007)]